CRYSTALLINE FORMS OF 4-AMINO-N-[4-(METHOXYMETHYL)PHENYL]-7-(1-METHYLCYCLOPROPYL)-6-(3-MORPHOLINOPROP-1-YN-1-YL)-7H-PYRROLO[2,3-D]PYRIMIDINE-5-CARBOXAMIDE, METHODS OF PREPARATION, AND USES THEREOF

Provided herein are various crystalline forms of 4-amino-N-[4-(methoxymethyl)phenyl]-7-(1- methylcyclopropyl)-6-(3-morpholinoprop-1-yn-1-yl)-7H-pyrrolo[2,3-d]pyrimidine-5- carboxamide, methods of producing same, and methods of using same to for RET inhibition. L'invention concerne diverses form...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FRASCA, Gionata, MODENA, Enrico, IANNI, Cristina, GIAFFREDA, Stefano Luca, FUMAGALLI, Tiziano
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator FRASCA, Gionata
MODENA, Enrico
IANNI, Cristina
GIAFFREDA, Stefano Luca
FUMAGALLI, Tiziano
description Provided herein are various crystalline forms of 4-amino-N-[4-(methoxymethyl)phenyl]-7-(1- methylcyclopropyl)-6-(3-morpholinoprop-1-yn-1-yl)-7H-pyrrolo[2,3-d]pyrimidine-5- carboxamide, methods of producing same, and methods of using same to for RET inhibition. L'invention concerne diverses formes cristallines de 4-amino-N-[4-(méthoxyméthyl)phényl]-7-(1-méthylcyclopropyle)-6-(3-morpholinoprop-1-yn-1-yl)-7 H-pyrrolo[2,3-d]pyrimidine-5-carboxamide, des procédés de production de celles-ci, et des procédés d'utilisation de celles-ci pour inhiber RET.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022106514A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022106514A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022106514A13</originalsourceid><addsrcrecordid>eNqNjkFqwzAQRb3poqS9gyAbBzwQ2U6yVi0ZCSSNGKs0IoQQiroqbSC9YS9Wxe0BupnP_D_M-_fV90BpisJa4xUbkdzEcGQ9CGc8godDD7VTUeM-3STZVdDKJ3uEHdQcfr0hDRYDYSgxbKHuwCEFjeXpbAOH5G-jxDsNIRGhxUPbdCCPZTPOyMKHDQyCnnBf4FI1bObKuVAgFQSJaNA3THjJnic1sagVKRwfqru38_s1P_7polqOKg4a8uXzlK-X82v-yF-nF2zXbcvX2w3vBe_-d_UDjQxO_A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CRYSTALLINE FORMS OF 4-AMINO-N-[4-(METHOXYMETHYL)PHENYL]-7-(1-METHYLCYCLOPROPYL)-6-(3-MORPHOLINOPROP-1-YN-1-YL)-7H-PYRROLO[2,3-D]PYRIMIDINE-5-CARBOXAMIDE, METHODS OF PREPARATION, AND USES THEREOF</title><source>esp@cenet</source><creator>FRASCA, Gionata ; MODENA, Enrico ; IANNI, Cristina ; GIAFFREDA, Stefano Luca ; FUMAGALLI, Tiziano</creator><creatorcontrib>FRASCA, Gionata ; MODENA, Enrico ; IANNI, Cristina ; GIAFFREDA, Stefano Luca ; FUMAGALLI, Tiziano</creatorcontrib><description>Provided herein are various crystalline forms of 4-amino-N-[4-(methoxymethyl)phenyl]-7-(1- methylcyclopropyl)-6-(3-morpholinoprop-1-yn-1-yl)-7H-pyrrolo[2,3-d]pyrimidine-5- carboxamide, methods of producing same, and methods of using same to for RET inhibition. L'invention concerne diverses formes cristallines de 4-amino-N-[4-(méthoxyméthyl)phényl]-7-(1-méthylcyclopropyle)-6-(3-morpholinoprop-1-yn-1-yl)-7 H-pyrrolo[2,3-d]pyrimidine-5-carboxamide, des procédés de production de celles-ci, et des procédés d'utilisation de celles-ci pour inhiber RET.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220527&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022106514A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220527&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022106514A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FRASCA, Gionata</creatorcontrib><creatorcontrib>MODENA, Enrico</creatorcontrib><creatorcontrib>IANNI, Cristina</creatorcontrib><creatorcontrib>GIAFFREDA, Stefano Luca</creatorcontrib><creatorcontrib>FUMAGALLI, Tiziano</creatorcontrib><title>CRYSTALLINE FORMS OF 4-AMINO-N-[4-(METHOXYMETHYL)PHENYL]-7-(1-METHYLCYCLOPROPYL)-6-(3-MORPHOLINOPROP-1-YN-1-YL)-7H-PYRROLO[2,3-D]PYRIMIDINE-5-CARBOXAMIDE, METHODS OF PREPARATION, AND USES THEREOF</title><description>Provided herein are various crystalline forms of 4-amino-N-[4-(methoxymethyl)phenyl]-7-(1- methylcyclopropyl)-6-(3-morpholinoprop-1-yn-1-yl)-7H-pyrrolo[2,3-d]pyrimidine-5- carboxamide, methods of producing same, and methods of using same to for RET inhibition. L'invention concerne diverses formes cristallines de 4-amino-N-[4-(méthoxyméthyl)phényl]-7-(1-méthylcyclopropyle)-6-(3-morpholinoprop-1-yn-1-yl)-7 H-pyrrolo[2,3-d]pyrimidine-5-carboxamide, des procédés de production de celles-ci, et des procédés d'utilisation de celles-ci pour inhiber RET.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjkFqwzAQRb3poqS9gyAbBzwQ2U6yVi0ZCSSNGKs0IoQQiroqbSC9YS9Wxe0BupnP_D_M-_fV90BpisJa4xUbkdzEcGQ9CGc8godDD7VTUeM-3STZVdDKJ3uEHdQcfr0hDRYDYSgxbKHuwCEFjeXpbAOH5G-jxDsNIRGhxUPbdCCPZTPOyMKHDQyCnnBf4FI1bObKuVAgFQSJaNA3THjJnic1sagVKRwfqru38_s1P_7polqOKg4a8uXzlK-X82v-yF-nF2zXbcvX2w3vBe_-d_UDjQxO_A</recordid><startdate>20220527</startdate><enddate>20220527</enddate><creator>FRASCA, Gionata</creator><creator>MODENA, Enrico</creator><creator>IANNI, Cristina</creator><creator>GIAFFREDA, Stefano Luca</creator><creator>FUMAGALLI, Tiziano</creator><scope>EVB</scope></search><sort><creationdate>20220527</creationdate><title>CRYSTALLINE FORMS OF 4-AMINO-N-[4-(METHOXYMETHYL)PHENYL]-7-(1-METHYLCYCLOPROPYL)-6-(3-MORPHOLINOPROP-1-YN-1-YL)-7H-PYRROLO[2,3-D]PYRIMIDINE-5-CARBOXAMIDE, METHODS OF PREPARATION, AND USES THEREOF</title><author>FRASCA, Gionata ; MODENA, Enrico ; IANNI, Cristina ; GIAFFREDA, Stefano Luca ; FUMAGALLI, Tiziano</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022106514A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>FRASCA, Gionata</creatorcontrib><creatorcontrib>MODENA, Enrico</creatorcontrib><creatorcontrib>IANNI, Cristina</creatorcontrib><creatorcontrib>GIAFFREDA, Stefano Luca</creatorcontrib><creatorcontrib>FUMAGALLI, Tiziano</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FRASCA, Gionata</au><au>MODENA, Enrico</au><au>IANNI, Cristina</au><au>GIAFFREDA, Stefano Luca</au><au>FUMAGALLI, Tiziano</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CRYSTALLINE FORMS OF 4-AMINO-N-[4-(METHOXYMETHYL)PHENYL]-7-(1-METHYLCYCLOPROPYL)-6-(3-MORPHOLINOPROP-1-YN-1-YL)-7H-PYRROLO[2,3-D]PYRIMIDINE-5-CARBOXAMIDE, METHODS OF PREPARATION, AND USES THEREOF</title><date>2022-05-27</date><risdate>2022</risdate><abstract>Provided herein are various crystalline forms of 4-amino-N-[4-(methoxymethyl)phenyl]-7-(1- methylcyclopropyl)-6-(3-morpholinoprop-1-yn-1-yl)-7H-pyrrolo[2,3-d]pyrimidine-5- carboxamide, methods of producing same, and methods of using same to for RET inhibition. L'invention concerne diverses formes cristallines de 4-amino-N-[4-(méthoxyméthyl)phényl]-7-(1-méthylcyclopropyle)-6-(3-morpholinoprop-1-yn-1-yl)-7 H-pyrrolo[2,3-d]pyrimidine-5-carboxamide, des procédés de production de celles-ci, et des procédés d'utilisation de celles-ci pour inhiber RET.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2022106514A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title CRYSTALLINE FORMS OF 4-AMINO-N-[4-(METHOXYMETHYL)PHENYL]-7-(1-METHYLCYCLOPROPYL)-6-(3-MORPHOLINOPROP-1-YN-1-YL)-7H-PYRROLO[2,3-D]PYRIMIDINE-5-CARBOXAMIDE, METHODS OF PREPARATION, AND USES THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T19%3A56%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FRASCA,%20Gionata&rft.date=2022-05-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022106514A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true